Traditional analytical methods encounter challenges when quantifying busulfan, an antineoplastic cancer therapy, due to its bioavailability. UPLC-MS/MS analysis with the ACQUITY UPLC I-Class PLUS and Xevo TQD Mass Spectrometer provides clinical research laboratories with highly selective and accurate data, as well as and rapid analysis and increased sensitivity.